Chemed (CHE) free cash flow

Free cash flow · fiscal 2025
$325.48M

Chemed (CHE) generated free cash flow of $325.48M in fiscal 2025 (the year ended December 31, 2025). That is 11.5% lower than the $367.97M of fiscal 2024. Figures as of 18 Nov 2026, 12:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$325.48M
Change on fiscal 2024
−11.5%
Growth, 5 years
−5.4% a year
Growth, 10 years
+9.8% a year
Highest on record
$430.46Mfiscal 2020
Lowest on record
$60.37Mfiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Chemed free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 5.4% a year; over ten years the rate was 9.8% a year. Across the 18 fiscal years on record (2008–2025), the highest was $430.46M in fiscal 2020 and the lowest $60.37M in fiscal 2010.

History · 18 fiscal years

Free cash flow by fiscal year

Chemed free cash flow, year by year

Chemed (CHE) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$325.48M 11.5% down
2024$367.97M 34.6% up
2023$273.45M 8.3% up
2022$252.56M 1.1% up
2021$249.92M 41.9% down
2020$430.46M 73.4% up
2019$248.23M 6.0% up
2018$234.27M 138.6% up
2017$98.20M 2.7% up
2016$95.62M 24.9% down
2015$127.37M 90.9% up
2014$66.71M 45.1% down
2013$121.52M 25.9% up
2012$96.52M 33.3% down
2011$144.75M 139.8% up
2010$60.37M 56.7% down
2009$139.34M 62.0% up
2008$85.99M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Chemed and comparable companies
CompanyFree cash flowFiscal year
Immunovant IMVT-$407.32M2026
Axsome Therapeutics AXSM-$93.89M2025
Chemed CHE$325.48M2025
Oruka Therapeutics ORKA-$88.42M2025
Arrowhead Pharmaceuticals ARWR-$283.94M2026
MSA Safety MSA$295.43M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CHE

Chemed, figure by figure

Chemed (CHE) overview: price, valuation and scorecardAll health care companies by market value

Chemed free cash flow: questions and answers

What is Chemed's free cash flow?

Chemed (CHE) generated free cash flow of $325.48M in fiscal 2025 (the year ended December 31, 2025). That is 11.5% lower than the $367.97M of fiscal 2024.

What is the growth rate of Chemed's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 5.4% a year; over ten years the rate was 9.8% a year.

What are the highest and lowest free cash flow figures on record for Chemed?

Across the 18 fiscal years on record (2008–2025), the highest was $430.46M in fiscal 2020 and the lowest $60.37M in fiscal 2010.

How is Chemed's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Chemed it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Chemed (CHE) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/CHE/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.